BRPI0816144A2 - Composição - Google Patents

Composição

Info

Publication number
BRPI0816144A2
BRPI0816144A2 BRPI0816144-5A2A BRPI0816144A BRPI0816144A2 BR PI0816144 A2 BRPI0816144 A2 BR PI0816144A2 BR PI0816144 A BRPI0816144 A BR PI0816144A BR PI0816144 A2 BRPI0816144 A2 BR PI0816144A2
Authority
BR
Brazil
Prior art keywords
composition
Prior art date
Application number
BRPI0816144-5A2A
Other languages
English (en)
Inventor
Jacob Hendrik Beijnen
Johannes Henricus Matthias Schellens
Johannes Moes
Bastiaan Nuijen
Original Assignee
Stichting Nl Kanker Inst
Slotervaart Participaties Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Nl Kanker Inst, Slotervaart Participaties Bv filed Critical Stichting Nl Kanker Inst
Priority claimed from PCT/GB2008/002854 external-priority patent/WO2009027644A2/en
Publication of BRPI0816144A2 publication Critical patent/BRPI0816144A2/pt

Links

BRPI0816144-5A2A 2007-08-24 2008-08-22 Composição BRPI0816144A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95776407P 2007-08-24 2007-08-24
GB0716591A GB0716591D0 (en) 2007-08-24 2007-08-24 Composition
PCT/GB2008/002854 WO2009027644A2 (en) 2007-08-24 2008-08-22 Composition

Publications (1)

Publication Number Publication Date
BRPI0816144A2 true BRPI0816144A2 (pt) 2015-02-18

Family

ID=38599259

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0816144-5A2A BRPI0816144A2 (pt) 2007-08-24 2008-08-22 Composição

Country Status (6)

Country Link
JP (1) JP5404625B2 (pt)
CN (1) CN101854919B (pt)
BR (1) BRPI0816144A2 (pt)
ES (1) ES2535401T3 (pt)
GB (1) GB0716591D0 (pt)
RU (1) RU2488384C2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR086913A1 (es) * 2011-06-14 2014-01-29 Novartis Ag 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]-amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil]-benzamida amorfa, forma de dosificacion que la contiene y metodo para prepararlas
WO2015152433A1 (en) * 2014-03-31 2015-10-08 Hanmi Pharm. Co., Ltd. Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same
CN105106420A (zh) * 2015-07-30 2015-12-02 马衍福 一种抗肿瘤疾病中药制剂
EP3595633B1 (en) 2017-03-15 2023-07-05 DFB Soria, LLC Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
WO2019047812A1 (zh) 2017-09-07 2019-03-14 深圳信立泰药业股份有限公司 多西他赛共缀物的药物组合物及制备方法
CA3124319C (en) * 2018-12-21 2023-07-04 Modra Pharmaceuticals B.V. Combination treatment for solid tumors using docetaxel and a cyp3a inhibitor
MX2021007478A (es) * 2018-12-21 2021-10-13 Modra Pharmaceuticals B V Uso prolongado de docetaxel en el tratamiento del cáncer.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371836C (en) * 1999-05-27 2006-01-31 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
EP1539111A1 (en) * 2002-08-05 2005-06-15 DSM IP Assets B.V. Oral dosage forms of water insoluble drugs and methods of making the same
KR100508518B1 (ko) * 2002-11-13 2005-08-17 한미약품 주식회사 초임계유체 공정을 이용한 파클리탁셀 고체분산체의 제조방법 및 이 방법으로 제조된 파클리탁셀 고체분산체
WO2004050068A1 (en) * 2002-11-29 2004-06-17 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
WO2006026592A2 (en) * 2004-08-27 2006-03-09 Spherics, Inc. Oral administration of poorly absorbed drugs, methods and compositions related thereto

Also Published As

Publication number Publication date
RU2488384C2 (ru) 2013-07-27
GB0716591D0 (en) 2007-10-03
JP5404625B2 (ja) 2014-02-05
JP2010536837A (ja) 2010-12-02
CN101854919B (zh) 2012-02-15
RU2010110658A (ru) 2011-09-27
ES2535401T3 (es) 2015-05-11
CN101854919A (zh) 2010-10-06

Similar Documents

Publication Publication Date Title
BRPI0813775A2 (pt) Composição
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
BRPI0810634A2 (pt) Composições fungicidas
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
BRPI0716325A2 (pt) Composição antimicrobianas
FR2899479B1 (fr) Composition cicatrisante
DE602008002756D1 (de) Bauzusammensetzung
ATE542825T1 (de) Substituierte piperidino-dihydrothienopyrimidine
BRPI0821573A2 (pt) benzofuropirimidonas
ATE501136T1 (de) Imidazopyridinone
IT1392101B1 (it) Composizione comprendente isoflavoni
BRPI0917231A2 (pt) composição
ATE514696T1 (de) Diphenyl-dihydro-imidazopyridinone
BRPI0810557A2 (pt) composição
BRPI0811274A2 (pt) Composição
BRPI0811451A2 (pt) Exopolissacarídeo
BRPI0814519A2 (pt) Organopolissiloxano
BRPI0812840A2 (pt) 2-imidazolinas
AT505058A3 (de) Türschliesssystem
BRPI0815547A2 (pt) Depsipeptídeos cícliocos
BRPI0811002A2 (pt) Composição biofertilizante
BRPI0812994A2 (pt) Microbiocidas
DE112008001216A5 (de) Magnetronplasmaanlage
BRPI0820960A2 (pt) composição

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]